CARMA FUND I is an early-stage investment fund focused on advancing the translation of Life Science and Healthcare assets. They provide capital to young companies and projects in the Life Science and medical space, recognizing the unique challenges and opportunities within the biotech/healthcare industry. They aim to support projects that have the potential to develop new products and services for patient well-being and medical advancements, which often struggle to attract reliable streams of outside capital. CARMA FUND I believes in supporting these projects to bring out their full potential, with a focus on quick and efficient development towards market entry. The fund is uniquely suited for young companies, offering an extra-long term, flexible investment modes, and close relationships with leading technology transfer offices and industry partners. CARMA FUND I welcomes funding applications from all European sources. This suggests a pan-European focus on identifying and supporting promising innovations in the life sciences and healthcare sectors. CARMA FUND I's approach is based on understanding the specialist nature of the Biotech/healthcare business and addressing the financing needs of innovators in this field. They strive to be a reliable source of capital, facilitating the development process towards successful market entry. Their partnerships with technology transfer offices and industry partners indicate a commitment to providing not only financial support but also valuable connections and expertise to their portfolio companies.
Preferred startup development maturity for initial funding deployment.
Life Science, Healthcare, Therapeutics, Medical Technologies
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...